Research summary ·
Efficacy and Safety of JAK Inhibitors in Lichen Planus: A Systematic Review of the Available Clinical Evidence.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review gathered past studies on JAK inhibitors for lichen planus. Lichen planus is a long-term immune disease. It can affect the skin, the linings of the body, hair and nails. The team searched research databases up to May 2026. They looked at how well these drugs worked and how safe they were. They also rated the quality of each study.
What they found
Most studies were reports on one person or a few people. Only a few controlled trials were found. Some drugs acted on the whole body, such as tofacitinib, upadacitinib and baricitinib. Others were put on the skin, such as ruxolitinib. With these drugs, itch and pain went down fast. After that, the inflamed spots cleared. Many people had a full or partial response, across many types of the disease. Short-term side effects were mostly mild and easy to manage. The authors rated the overall certainty of the evidence as low.
What it means for patients
The authors say JAK inhibitors show early signs of a response in hard-to-treat lichen planus. To them, short-term safety looked acceptable. They see these drugs as a useful other option to usual care. Usual care includes steroids and drugs that calm the immune system. The authors say these often help too little and cause unwanted side effects.
Why it is not certain yet
Most of the evidence came from case reports and other observational studies. Few controlled trials were found. The certainty of the evidence was low. Safety beyond the short term is not known. The authors say large randomized trials with long follow-up are needed. Such trials could find the proper dose and confirm safety. They could also show if the benefit lasts. A review can only be as good as the studies in it.
Source
Efficacy and Safety of JAK Inhibitors in Lichen Planus: A Systematic Review of the Available Clinical Evidence.
PubMed · PMID 42482673We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Lichen planus publications